APA
CODX

American Portfolios Advisors’s Co-Diagnostics CODX Stock Holding History

American Portfolios Advisors’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43
Closed -$8.03K – 3550
2022
Q1 		$8.03K Hold
43
– – ﹤0.01% 2778
2021
Q4 		$11.6K Sell
43
-34
-44% -$8.92K ﹤0.01% 2569
2021
Q3 		$22.4K Hold
77
– – ﹤0.01% 2233
2021
Q2 		$19K Hold
77
– – ﹤0.01% 2251
2021
Q1 		$21.9K Buy
+77
New +$30.7K ﹤0.01% 2019

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Portfolios Advisors's CODX Position: Q2 2022 in Review

American Portfolios Advisors sold out of Co-Diagnostics (CODX) in Q2 2022, closing a stake of 43 shares — an estimated $8.03K sold.

American Portfolios Advisors first reported a position in CODX in Q1 2021 and held it in 5 quarters. The position peaked at $22.4K in Q3 2021. 69 funds tracked by Wall St. Rank hold CODX as of Q2 2022.

  • American Portfolios Advisors reported no remaining Co-Diagnostics position as of Q2 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 43 Co-Diagnostics shares in Q2 2022, an estimated $8.03K.
  • American Portfolios Advisors first reported a position in Co-Diagnostics in Q1 2021 and held it in 5 quarters.
  • American Portfolios Advisors's Co-Diagnostics position peaked at $22.4K in Q3 2021.
  • 69 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.